Aleksander Prejbisz Selected Research

Calcium

1/2017	Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
1/2013	Primary aldosteronism - recent progress and current concepts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleksander Prejbisz Research Topics

Disease

34	Hypertension (High Blood Pressure) 05/2024 - 01/2003
23	Paraganglioma (Paragangliomas) 01/2022 - 02/2008
17	Pheochromocytoma 01/2022 - 02/2008
15	Neoplasms (Cancer) 01/2023 - 04/2015
12	Hyperaldosteronism (Conn Syndrome) 03/2024 - 01/2003
5	Adenoma (Adenomas) 01/2020 - 01/2003
4	Heart Failure 01/2023 - 01/2013
3	Chronic Renal Insufficiency 01/2023 - 01/2013
3	Essential Hypertension 08/2022 - 06/2014
3	Obstructive Sleep Apnea 01/2021 - 10/2011
3	Hyperplasia 01/2018 - 01/2003
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 06/2003
2	COVID-19 01/2024 - 11/2022
2	Obesity 01/2022 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 06/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2003
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 12/2014
2	Pathologic Constriction (Stenosis) 01/2021 - 01/2021
2	Renal Insufficiency (Renal Failure) 01/2016 - 01/2012
2	Glucose Intolerance 01/2013 - 10/2011
2	Renal Artery Obstruction (Renal Artery Stenosis) 01/2013 - 06/2003
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2013 - 10/2011
1	Diabetes Mellitus 01/2024
1	Atherosclerosis 01/2024
1	Adrenocortical Carcinoma 01/2022
1	Adrenal incidentaloma 01/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022
1	Hypertrophy 12/2020
1	Atrial Fibrillation 09/2020
1	Vascular Remodeling 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Weight Gain 01/2019
1	Hypoxia (Hypoxemia) 04/2017
1	Cardiomegaly (Heart Hypertrophy) 01/2017
1	Mood Disorders (Mood Disorder) 01/2016
1	Papilledema 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Malignant Hypertension 01/2016
1	Hemorrhage 01/2016

Drug/Important Bio-Agent (IBA)

18	CatecholaminesIBA 01/2023 - 11/2011
13	Antihypertensive Agents (Antihypertensives)IBA 05/2024 - 01/2003
10	NormetanephrineIBA 01/2022 - 03/2013
10	MetanephrineIBA 12/2020 - 03/2013
7	AldosteroneIBA 03/2024 - 01/2003
7	3-methoxytyramine (methoxytyramine)IBA 01/2022 - 01/2014
6	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2022 - 02/2008
4	SteroidsIBA 01/2024 - 01/2020
3	ReninIBA 03/2024 - 01/2014
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 04/2017
3	Dopamine (Intropin)FDA LinkGeneric 08/2017 - 03/2013
3	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 10/2011
2	Drug CombinationsIBA 01/2024 - 01/2017
2	SaltsIBA 06/2023 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2017
2	Angiotensin Receptor AntagonistsIBA 11/2022 - 06/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2022 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 08/2022 - 12/2011
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 11/2020 - 04/2017
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2016
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019 - 02/2015
2	Hormones (Hormone)IBA 01/2019 - 01/2013
2	CalciumIBA 01/2017 - 01/2013
2	Mineralocorticoid Receptor AntagonistsIBA 01/2016 - 01/2015
2	Cystatin CIBA 02/2015 - 01/2010
1	Lipoprotein(a)IBA 01/2024
1	Dietary SodiumIBA 06/2023
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2022
1	DiureticsIBA 11/2022
1	C-Reactive ProteinIBA 11/2022
1	ThiazidesIBA 11/2022
1	LipidsIBA 01/2022
1	FibrinIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	lipoprotein cholesterolIBA 01/2022
1	Cytidine Monophosphate (CMP)IBA 01/2021
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 12/2020
1	Cortodoxone (11 Deoxycortisol)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	CorticosteroneIBA 01/2020
1	Contraceptive Agents (Contraceptives)IBA 01/2019
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2017
1	EnzymesIBA 09/2016
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2016
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2016
1	mahuang-tangIBA 01/2016
1	Keratins (Keratin)IBA 04/2015
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2015
1	ChromograninsIBA 04/2015
1	SynaptophysinIBA 04/2015

Therapy/Procedure

8	Therapeutics 01/2024 - 01/2003
7	Denervation 01/2021 - 10/2011
7	Adrenalectomy 12/2020 - 01/2016
6	Catheters 01/2021 - 01/2011
4	Sympathectomy (Sympathectomies) 01/2021 - 01/2011
2	Drug Therapy (Chemotherapy) 11/2022 - 01/2017
1	Bariatric Surgery 01/2022
1	Renal Dialysis (Hemodialysis) 01/2021